title: [The Qualitative Analysis of the Amide Derivative of HLDF-6 Peptide and Its Metabolites with the Use of Tritium- and Deuterium-Labeled Derivatives].
abstract: The goal of the study was to elaborate the pharmacokinetics methods of the amide derivative of peptide HLDF-6 (TGENHR-NH2) and its range of nootropic and neuroprotective activity is wide. The hexapeptide 41TGENHR46 is a fragment of the HDLF differentiation factor. It forms the basis for the development of preventive and therapeutic preparations for treating cerebrovascular and neurodegenerative conditions. Pharmacokinetic and molecular mechanisms of the action of the HLDF-6 peptide were studied using tritium- and deuterium-labeled derivatives of this peptide, produced with the use of the high-temperature solid-state catalytic isotope exchange reaction (HSCIE). This reaction was employed to produce the tritium-labeled peptide [3H]TGENHR-NH2 with a molar radioactivity of 230 Ci/mmol and the deuterium-labeled peptide [2H]TGENHR-NH2 with an average deuterium incorporation equal to 10.5 atoms. It was shown by the NMR spectroscopy that the isotope label distribution over the labeled peptide's molecule was uniform, which allowed qualitative analysis ofboth the peptide itself and its fragments in the organism's tissues to be conducted. The newly developed pharmacokinetics method makes it possible to avoid almost completely losses of the peptides under study due to biodegradation during the analysis of tissues. These labeled peptides were used in mice, rats and rabbits to study the pharmacokinetics of the peptide and to calculate the values of its principal pharmacokinetic parameters. Characteristics of its pharmacokinetic profile in the blood were obtained, the hypothesis of pharmacokinetics linearity tested, its metabolism analyzed and its bioavailability value, 34%, calculated. It has been shown that the studied TGENHR-NH2 peptide shows high resistance to hydrolysis in the blood plasma, with dipeptidyl aminopeptidases making the largest contribution to its hydrolysis.
authors.forename: A
authors.initials: A
authors.lastname: Zolotarev
authors.forename: A K
authors.initials: AK
authors.lastname: Dadayan
authors.forename: N V
authors.initials: NV
authors.lastname: Kost
authors.forename: M E
authors.initials: ME
authors.lastname: Voevodina
authors.forename: O Y
authors.initials: OY
authors.lastname: Sokolov
authors.forename: V S
authors.initials: VS
authors.lastname: Kozik
authors.forename: S I
authors.initials: SI
authors.lastname: Shram
authors.forename: V N
authors.initials: VN
authors.lastname: Azev
authors.forename: E V
authors.initials: EV
authors.lastname: Bocharov
authors.forename: A P
authors.initials: AP
authors.lastname: Bogachouk
authors.forename: V M
authors.initials: VM
authors.lastname: Lipkin
authors.forename: N F
authors.initials: NF
authors.lastname: Myasoedov
mesh_terms: D000818:Animals; D003903:Deuterium / Q000737:chemistry*; D006801:Humans; D007553:Isotope Labeling; D051379:Mice; D009842:Oligopeptides / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D014316:Tritium / Q000737:chemistry*
chemical_list: D009842:Oligopeptides; C513648:threonyl-glycyl-glutamyl-asparaginyl-histidylarginine; D014316:Tritium; D003903:Deuterium